Do you or a loved one have relapsing MS?
The BEAT-MS study may be an option.
If you are at least 18 and have continued relapses or active MRI while taking prescription medicine for MS, you may be eligible.
There are a number of U.S. Clinical Research Study Sites where participants will be enrolled in the BEAT-MS study.
A clinical trial comparing hemato-poietic stem cell transplantation to the most effective medications used to treat relapsing multiple sclerosis (MS).